Alyeska Investment Group
NEXI

Alyeska Investment Group’s NexImmune, Inc. Common Stock NEXI Stock Holding History

Alyeska Investment Group’s Portfolio NEXI Stock Details NEXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-457
Closed -$186K – 823
2021
Q2 		$186K Sell
457
-2,543
-85% -$1.17M ﹤0.01% 688
2021
Q1 		$1.43M Buy
+3,000
New +$1.63M 0.02% 529

Other funds holding NEXI

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AO
Allen Operations New York $670M AUM 26.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Alyeska Investment Group's NEXI Position: Q3 2021 in Review

Alyeska Investment Group sold out of NexImmune, Inc. Common Stock (NEXI) in Q3 2021, closing a stake of 457 shares — an estimated $186K sold.

Alyeska Investment Group first reported a position in NEXI in Q1 2021 and held it in 2 quarters. The position peaked at $1.43M in Q1 2021. 47 funds tracked by Wall St. Rank hold NEXI as of Q3 2021.

  • Alyeska Investment Group reported no remaining NexImmune, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Alyeska Investment Group sold 457 NexImmune, Inc. Common Stock shares in Q3 2021, an estimated $186K.
  • Alyeska Investment Group first reported a position in NexImmune, Inc. Common Stock in Q1 2021 and held it in 2 quarters.
  • Alyeska Investment Group's NexImmune, Inc. Common Stock position peaked at $1.43M in Q1 2021.
  • 47 funds tracked by Wall St. Rank held NexImmune, Inc. Common Stock as of Q3 2021.

Based on Alyeska Investment Group's 13F filing for Q3 2021, filed 15 Nov 2021.